Andorra Cyclists Regada and Sinfreu Eye Worlds Success in Montreal

Andorra's cyclists Adrià Regada and Eric Sinfreu, accompanied by Andorran Cycling Federation technical director Víctor de la Parte, will represent the country at the Road World Championships in Montreal. The delegation departs for Canada on Monday after a presentation event on Friday at Andbank's auditorium.

Regada, in his third under-23 appearance, targets a top-35 finish in the 174.2km road race on September 25, which features 3,497m of elevation gain over 13 laps of the Mont-Royal circuit. He expects the demanding four-and-a-half-minute climb and key positioning sections in the peloton to play to his strengths, bolstered by prior experience. "This year I have more experience, as it will be my third participation in the Worlds, and I think the course suits me well," Regada said. Beyond the result, he seeks UCI points while continuing with Caja Rural's under-23 team next season amid a tough transfer market marked by two teams folding. He aims to secure a WorldTour professional seat.

Sinfreu makes his junior debut the previous day, September 24, over 134km and 2,690m of climbing across 10 laps. The 18-year-old, in his first full competitive season, prioritizes finishing before assessing the field. "I don't know what we'll face, so it'll be on the first lap that I see what I can aim for," he explained. Early struggles adapting to the peloton have given way to victories and growing confidence. Representing Andorra carries pride and responsibility, he added.

De la Parte noted both riders arrive in top form but cautioned about the long flight, jet lag, and end-of-season fatigue. No additional under-23 rider was selected due to limited slots and competition risks, while no women qualified at the required level. The federation highlighted promising youth development for future international gains.

The junior race begins at 7:30pm Andorran time on Thursday, followed by the under-23 event at 3pm Friday. Regada placed 47th last year, building on consistent progress.